New diabetes clinical trial: A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

Published on: April 01, 2024 at 11:00PM
Conditions: Diabetes, Type 2
Interventions: Drug: Insulin icodec; Drug: Insulin glargine
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/haM0X1u